2XE1
Molecular insights into clinically isolated OmpC mutants and their role in multi-drug resistance
Replaces: 2IXXExperimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | ESRF BEAMLINE ID14-1 |
| Synchrotron site | ESRF |
| Beamline | ID14-1 |
| Temperature [K] | 100 |
| Detector technology | CCD |
| Detector | ADSC CCD |
| Spacegroup name | P 63 2 2 |
| Unit cell lengths | 120.400, 120.400, 158.100 |
| Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
| Resolution | 47.030 - 2.500 |
| R-factor | 0.19414 |
| Rwork | 0.193 |
| R-free | 0.21812 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 1osm |
| RMSD bond length | 0.005 |
| RMSD bond angle | 0.881 |
| Data reduction software | MOSFLM |
| Data scaling software | SCALA |
| Phasing software | MOLREP |
| Refinement software | REFMAC (5.6.0060) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 47.000 | 2.500 |
| High resolution limit [Å] | 2.500 | 2.500 |
| Rmerge | 0.100 | 0.520 |
| Number of reflections | 22833 | |
| <I/σ(I)> | 14 | 3.4 |
| Completeness [%] | 99.5 | 99.5 |
| Redundancy | 9 | 9 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 |






